Trials / Completed
CompletedNCT00871416
Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles
Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles. Furthermore, the Thickness of Cutis/Subcutis Is Measured on Recommended Insulin Injection Sites
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. The primary aim of this clinical trial is to locate and compare simulated insulin injections (injections of sterile atmospheric air) in normal weight and obese patients with diabetes mellitus. Injections are done with 6 mm and 12 mm needles with and without lifting of skin fold at different injection sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovoFine® needle 6 mm | |
| DEVICE | NovoFine® needle 12 mm |
Timeline
- Start date
- 1997-04-09
- Primary completion
- 1997-07-18
- Completion
- 1997-07-18
- First posted
- 2009-03-30
- Last updated
- 2017-02-28
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00871416. Inclusion in this directory is not an endorsement.